Terug
51
Dagbereik
€ 41,13
€ 43,61
52-Weeksbereik
€ 15,48
€ 44,87
Volume
2.090.755
50D / 200D Gem.
€ 40,00
/
€ 31,00
Vorige Slotkoers
€ 42,10
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 44,0 | 0,3 |
| P/B | 4,5 | 2,9 |
| ROE % | 10,8 | 3,7 |
| Net Margin % | 1,5 | 3,8 |
| Rev Growth 5Y % | 17,8 | 10,0 |
| D/E | 1,5 | 0,2 |
Koersdoel Analisten
Hold
€ 44,18
+2.0%
Low: € 32,00
High: € 55,00
Forward K/W
27,1
Forward WPA
€ 1,55
WPA Groei (sch.)
+0,0%
Omzet Sch.
15 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 5,24
€ 4,91 – € 5,42
|
28 B | 2 |
| FY2029 |
€ 3,61
€ 3,38 – € 3,73
|
23 B | 2 |
| FY2028 |
€ 2,60
€ 2,27 – € 3,22
|
19 B | 4 |
Belangrijkste Punten
Revenue grew 17,83% annually over 5 years — strong growth
ROE of 10,82% — decent returns on equity
Generating 394,69M in free cash flow
P/E of 43,96 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,24%
Cash machine — converts 207,00% of earnings into free cash flow
Groei
Revenue Growth (5Y)
17,83%
Revenue (1Y)14,59%
Earnings (1Y)N/A
FCF Growth (3Y)69,57%
Kwaliteit
Return on Equity
10,82%
ROIC6,29%
Net Margin1,48%
Op. Margin3,06%
Veiligheid
Debt / Equity
1,52
Current Ratio1,57
Interest Coverage2,51
Waardering
P/E Ratio
43,96
P/B Ratio4,47
EV/EBITDA28,16
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14,59% | Revenue Growth (3Y) | 20,94% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 17,83% | Earnings Growth (5Y) | 39,88% |
| Profitability | |||
| Revenue (TTM) | 12,91B | Net Income (TTM) | 190,67M |
| ROE | 10,82% | ROA | 2,97% |
| Gross Margin | 11,76% | Operating Margin | 3,06% |
| Net Margin | 1,48% | Free Cash Flow (TTM) | 394,69M |
| ROIC | 6,29% | FCF Growth (3Y) | 69,57% |
| Safety | |||
| Debt / Equity | 1,52 | Current Ratio | 1,57 |
| Interest Coverage | 2,51 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 43,96 | P/B Ratio | 4,47 |
| P/S Ratio | 0,65 | PEG Ratio | -0,04 |
| EV/EBITDA | 28,16 | Dividend Yield | 0,00% |
| Market Cap | 8,38B | Enterprise Value | 11,14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 12,91B | 11,27B | 8,83B | 7,72B | 6,70B |
| Net Income | 190,67M | -18,06M | -154,60M | -53,91M | 49,80M |
| EPS (Diluted) | 0,87 | -0,09 | -0,90 | -0,31 | 0,29 |
| Gross Profit | 1,52B | 1,59B | 1,43B | 1,35B | 1,25B |
| Operating Income | 395,46M | 206,37M | 147,18M | 187,83M | 234,18M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,41B | 5,93B | 5,53B | 5,44B | 5,51B |
| Total Liabilities | 4,53B | 4,27B | 4,92B | 4,66B | 4,71B |
| Shareholders' Equity | 1,88B | 1,65B | 584,74M | 754,78M | 774,82M |
| Total Debt | 2,84B | 2,90B | 3,67B | 3,68B | 3,77B |
| Cash & Equivalents | 88,37M | 61,25M | 13,07M | 13,63M | 46,74M |
| Current Assets | 2,89B | 1,89B | 1,46B | 1,34B | 1,18B |
| Current Liabilities | 1,85B | 1,43B | 1,25B | 932,51M | 892,16M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#173 of 618
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026